Sartorius Stedim BioOutsource set to double Glasgow workforce in 2016

To Continue Building Analytical Capabilities for Testing Drugs and Vaccines Glasgow, UK – April 27, 2016: Sartorius Stedim BioOutsource, a leading provider of contract testing services to the biopharmaceutical industry, is pleased to announce that it is looking to almost double the scientific workforce at its Glasgow facilities in 2016. The new staff will help More

New Webinar: Optimizing Analytics for Biosimilars

How Providing Comprehensive Data Can Accelerate Drug Development Glasgow, UK – April 21, 2016: Sartorius Stedim BioOutsource today announced that its scientific experts will be presenting a live webinar about optimizing biosimilar analysis on Thursday, June 2, at 3 pm BST, 10 am EDT. The webinar is essential listening for researchers who want to understand More

Sartorius Stedim BioOutsource Introduces Assays for Testing Biosimilarity of Three Leading Biologics

New ready-to-use assays enable quick and simple generation of precise biosimilar comparability data Glasgow, UK – March 22, 2016: Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, presents a range of ready-to-use assays for testing Actemra, Stelara and Lucentis biosimilars. The new assays, launched by SSB’s subsidiary Sartorius Stedim BioOutsource, will More

New Video on ADCC Assays from BioOutsource

Rapidly reveals the factors to consider when using ADCC assays for producing precise biosimilar comparability data Glasgow, UK – November 17, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced a new video is now available on-line explaining how to overcome the issues associated with using antibody-dependent cell-mediated cytotoxicity (ADCC) assays. The bite-sized video outlines the More

BioOutsource Bioanalysis Experts Attending Major Biosimilar Conferences November 16-19

Offering scientists an opportunity for face-to-face meetings to discuss strategies for accelerating biosimilar development Glasgow, UK – November 12, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with More

New Paper on using ADCC Assays to Prove Comparability of Biosimilars

Presents data on factors that affect the sensitivity of ADCC assays and discusses how to optimise methodology Glasgow, UK – November 10, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced a new paper entitled, ‘As easy as ADCC’ has been published in the respected journal, European Biopharmaceutical Review. The article outlines the factors affecting the More

BioOutsource Opens New Facility in Glasgow

Doubles the Company’s Capacity for Biologics Contract Testing and Biosimilar Characterisation in Response to Surging Demand, and Creates 50 New Jobs Glasgow, Scotland, July 27, 2015 – BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, today announced the opening More

BioOutsource Ltd. Acquired by Sartorius Stedim Biotech

Takeover expands SSB’s service portfolio Glasgow, April 17, 2015 – BioOutsource Ltd. (BioOutsource), a leading provider of contract testing services for the biopharmaceutical industry, has been acquired by Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries. BioOutsource provides contract testing services to Global biopharmaceutical clients in order to monitor the safety More

BioOutsource to Host Webinar on Biosimilar Comparability on Thursday, 12 February

Free Webinar to Explore Comparability Challenges Faced by Developers of Biosimilars GLASGOW, Scotland and CAMBRIDGE, Mass. – 9 February 2015 – BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced that it will be hosting a free webinar on Thursday, 12 February, at 3:00 p.m. More